PTC Therapeutics, Inc. Income Taxes Paid
PTC Therapeutics, Inc. (PTCT) reported Income Taxes Paid of $6.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-07-30
- PTC Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-12-31 was -$3.27M, a 168.57% decline year-over-year.
- PTC Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $936.00K, a 85.95% decline year-over-year.
- PTC Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-06-30 was $36.15M, a 787.07% increase year-over-year.
- PTC Therapeutics, Inc. income taxes paid, net for the quarter ending 2025-03-31 was $3.04M, a 48.87% increase year-over-year.
- PTC Therapeutics, Inc. income taxes paid, net for fiscal 2025 was $36.85M, a 109.99% increase from fiscal 2024.
- PTC Therapeutics, Inc. income taxes paid, net for fiscal 2024 was $17.55M, a 23.98% increase from fiscal 2023.
- PTC Therapeutics, Inc. income taxes paid, net for fiscal 2023 was $14.15M, a 187.59% increase from fiscal 2022.
- PTC Therapeutics, Inc. income taxes paid, net for fiscal 2022 was $4.92M, a 36.14% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.11M 10-Q · filed 2026-07-30 | ||||
| 2025-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.33M derived: sum of 2 quarters · filed 2026-02-19 | $33.81M derived: sum of 3 quarters · filed 2026-07-30 | $36.85M 10-K · filed 2026-02-19 | |
| 2025-09-30 | $936.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $37.08M derived: sum of 2 quarters · filed 2026-07-30 | $40.12M 10-Q · filed 2025-11-04 | $44.89M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $36.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $39.19M 10-Q · filed 2026-07-30 | $43.96M derived: sum of 3 quarters · filed 2026-07-30 | $50.62M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $3.04M 10-Q · filed 2025-05-06 | $7.81M derived: sum of 2 quarters · filed 2026-02-19 | $14.47M derived: sum of 3 quarters · filed 2026-02-19 | $18.55M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.43M derived: sum of 2 quarters · filed 2026-02-19 | $15.51M derived: sum of 3 quarters · filed 2026-02-19 | $17.55M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $10.74M derived: sum of 2 quarters · filed 2025-11-04 | $12.78M 10-Q · filed 2025-11-04 | $13.30M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.12M 10-Q · filed 2025-08-07 | $6.64M derived: sum of 3 quarters · filed 2026-02-19 | $11.08M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | $2.04M 10-Q · filed 2025-05-06 | $2.57M derived: sum of 2 quarters · filed 2026-02-19 | $7.00M derived: sum of 3 quarters · filed 2026-02-19 | $13.98M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.96M derived: sum of 2 quarters · filed 2026-02-19 | $11.94M derived: sum of 3 quarters · filed 2026-02-19 | $14.15M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.42M derived: sum of 2 quarters · filed 2024-11-07 | $13.63M 10-Q · filed 2024-11-07 | $14.52M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $6.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.20M 10-Q · filed 2024-08-08 | $10.09M derived: sum of 3 quarters · filed 2025-02-27 | $11.17M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $2.21M 10-Q · filed 2024-04-25 | $3.11M derived: sum of 2 quarters · filed 2025-02-27 | $4.19M derived: sum of 3 quarters · filed 2025-02-27 | $5.15M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.97M derived: sum of 2 quarters · filed 2025-02-27 | $2.94M derived: sum of 3 quarters · filed 2025-02-27 | $4.92M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $2.04M derived: sum of 2 quarters · filed 2023-10-26 | $4.03M 10-Q · filed 2023-10-26 | $6.21M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $962.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.95M 10-Q · filed 2023-08-03 | $5.13M derived: sum of 3 quarters · filed 2024-02-29 | $6.53M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $1.99M 10-Q · filed 2023-04-27 | $4.17M derived: sum of 2 quarters · filed 2024-02-29 | $5.57M derived: sum of 3 quarters · filed 2024-02-29 | $9.01M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.58M derived: sum of 2 quarters · filed 2024-02-29 | $7.02M derived: sum of 3 quarters · filed 2024-02-29 | $7.71M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $4.84M derived: sum of 2 quarters · filed 2022-10-27 | $5.53M 10-Q · filed 2022-10-27 | $30.36M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.13M 10-Q · filed 2022-08-04 | $28.96M derived: sum of 3 quarters · filed 2023-02-21 | $29.38M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $687.00K 10-Q · filed 2022-05-03 | $25.52M derived: sum of 2 quarters · filed 2023-02-21 | $25.94M derived: sum of 3 quarters · filed 2023-02-21 | $26.58M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $24.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $25.26M derived: sum of 2 quarters · filed 2023-02-21 | $25.89M derived: sum of 3 quarters · filed 2023-02-21 | $26.40M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.05M derived: sum of 2 quarters · filed 2021-10-28 | $1.56M 10-Q · filed 2021-10-28 | $1.74M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.14M 10-Q · filed 2021-07-29 | $1.32M derived: sum of 3 quarters · filed 2022-02-22 | $2.24M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $507.00K 10-Q · filed 2021-05-04 | $685.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.60M derived: sum of 3 quarters · filed 2022-02-22 | $2.08M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.10M derived: sum of 2 quarters · filed 2022-02-22 | $1.57M derived: sum of 3 quarters · filed 2022-02-22 | $2.11M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $918.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.39M derived: sum of 2 quarters · filed 2020-10-29 | $1.93M 10-Q · filed 2020-10-29 | $2.60M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $476.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.01M 10-Q · filed 2020-08-05 | $1.68M derived: sum of 3 quarters · filed 2021-02-25 | $1.84M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $537.00K 10-Q · filed 2020-04-30 | $1.20M derived: sum of 2 quarters · filed 2021-02-25 | $1.36M derived: sum of 3 quarters · filed 2021-02-25 | $1.79M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $825.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.26M derived: sum of 3 quarters · filed 2021-02-25 | $1.58M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $593.00K derived: sum of 2 quarters · filed 2019-10-30 | $919.00K 10-Q · filed 2019-10-30 | $1.40M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $758.00K 10-Q · filed 2019-08-06 | $1.24M derived: sum of 3 quarters · filed 2020-03-02 | $1.52M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $326.00K 10-Q · filed 2019-05-02 | $811.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.09M derived: sum of 3 quarters · filed 2020-03-02 | $1.40M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $767.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.07M derived: sum of 3 quarters · filed 2020-03-02 | $1.10M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $588.00K derived: sum of 2 quarters · filed 2018-11-05 | $616.00K 10-Q · filed 2018-11-05 | $926.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $306.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $334.00K 10-Q · filed 2018-08-07 | $644.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.01M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $28.00K 10-Q · filed 2018-05-09 | $338.00K derived: sum of 2 quarters · filed 2019-03-01 | $707.00K derived: sum of 3 quarters · filed 2019-03-01 | $746.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $679.00K derived: sum of 2 quarters · filed 2019-03-01 | $718.00K derived: sum of 3 quarters · filed 2019-03-01 | $943.00K 10-K · filed 2019-03-01 | |
| 2016-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $408.00K derived: sum of 2 quarters · filed 2017-11-02 | $633.00K 10-Q · filed 2017-11-02 | $744.00K derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $264.00K 10-Q · filed 2017-08-09 | $375.00K derived: sum of 3 quarters · filed 2018-03-06 | ||
| 2016-03-31 | $225.00K 10-Q · filed 2017-05-08 | $336.00K derived: sum of 2 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $111.00K 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 | ||||
| 2013-12-31 | $2.00K 10-K · filed 2016-02-29 | $2.08K 10-K · filed 2014-03-06 | |||
| 2012-12-31 | $2.00K 10-K · filed 2015-03-02 | ||||
| 2011-12-31 | $2.08K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |